Werner Mathias
Institute of Osteopathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Int Orthop. 2006 Dec;30(6):484-9. doi: 10.1007/s00264-006-0215-7. Epub 2006 Sep 30.
The giant cell tumour of bone (GCT) is a locally aggressive intraosseous neoplasm of obscure biological behaviour. Although well defined in clinical, radiological and histological terms, detailed information on its biological development is still relatively incomplete. The tumoral tissue consists of three cell types--the neoplastic giant cell tumour stromal cells (GCTSC), representing the proliferative fraction, secondarily recruited mononuclear histiocytic cells (MNHC) and multinuclear giant cells (MNGC). These cellular components interact together with factors that have a role in regulating osteoclast function in normal bone tissue (e.g. RANK, RANKL, OPG, M-CSF). Recent publications suggest that the neoplastic stromal cells express differentiation features of mesenchymal stem cells. Further research of the pathogenesis of GCT as well as the complex interactions of its cellular populations may provide the knowledge necessary for developing approaches for a biological-based therapy of this neoplasm.
骨巨细胞瘤(GCT)是一种具有局部侵袭性的骨内肿瘤,其生物学行为尚不明确。尽管在临床、放射学和组织学方面已有明确界定,但关于其生物学发展的详细信息仍相对不完整。肿瘤组织由三种细胞类型组成——肿瘤性巨细胞瘤基质细胞(GCTSC),代表增殖部分,其次是募集的单核组织细胞(MNHC)和多核巨细胞(MNGC)。这些细胞成分与在正常骨组织中调节破骨细胞功能的因子(如RANK、RANKL、OPG、M-CSF)相互作用。最近的出版物表明,肿瘤基质细胞表达间充质干细胞的分化特征。对GCT发病机制及其细胞群体复杂相互作用的进一步研究,可能为开发基于生物学的该肿瘤治疗方法提供必要的知识。